Trial Profile
Phase I/II study of controlled-release interferon alpha-2b vs immediate-release interferon alpha-2b in chronic hepatitis C
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Interferon alpha-2b (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Biomarker
- 05 Nov 2010 New trial record.